Abstract: Described is a process mixture for use in and/or for the manufacture of one or more dry films, an article for use in an electrochemical device, a method for making a dry film or an article for an electrochemical device. The dry films can be incorporated in an article. The article can be incorporated in an electrochemical device. The process mixture ingredients may comprise one or more reactive materials and/or reactive composites. The reactive composite may comprise one or more reactive materials and one or more matrix materials. The reactive composite or the process mixture may comprise one or more binders. The process mixture may be a dry blend or a paste. One or more binders may be fibrillizable and/or is fibrillized. The dry blend may be made from a paste. The article may comprise a dry film derived from a process mixture. The dry film may be an element of an anode and/or a cathode.

Abstract: Embodiments described herein provide for the leveraging of edge-based resources (e.g., processing, memory, storage, and/or other resources of one or more Multi-Access/Mobile Edge Computing devices (“MECs”), such as MECs associated with a radio access network (“RAN”) of a wireless network) to process data from and/or provide instructions to microcontroller devices, System on Chip (“SoC”) devices, configurable logic boards, Internet of Things (“IoT”) devices, and/or other types of devices or systems. For example, embodiments described herein may provide for the creation and configuration of logical devices or systems based on one or more microcontrollers, SoC devices, etc., edge-based processing of sensor data and/or other types of data received or generated by the microcontrollers, SoC devices, etc., and the generation of instructions to control physical devices communicatively coupled to the microcontrollers, SoC devices, etc.

Abstract: The present invention relates to a composition comprising ibudilast, or a pharmaceutically acceptable salt thereof, for use in the treatment of Fragile X syndrome, wherein the composition does not comprise sulindac, or a pharmaceutically acceptable salt thereof, or bumetanide, or a pharmaceutically acceptable salt thereof.

Abstract: Described herein are compounds, including pharmaceutically acceptable salts and solvates thereof, methods of making such compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat non-alcoholic steatohepatitis and other diseases characterized by dysfunctional tissue healing and fibrosis.

Abstract: A gas turbine engine for an aircraft. The engine including: an engine core with a turbine, a compressor, a fan located upstream of the compressor and including a plurality of fan blades, and a core shaft connecting the turbine to the compressor; a gearbox which receives an input from the core shaft and outputs drive, via a driveshaft, to the fan so as to drive the fan at a lower rotational speed than the turbine, the drive shaft and core shaft forming a shaft system.

Abstract: Exemplary embodiments of the disclosure may be drawn to a device having an inlet and a chamber. Immobilized lipase, immobilized protease, and immobilized amylase may be contained within the chamber. The device may also include an outlet, wherein a flow path extends from the inlet, through the chamber, and to the outlet.

Abstract: Disclosed herein are devices, systems, and methods for accurately determining fluid level using Ultra Wideband (UWB) positioning or localization. UWB utilizes a radio-frequency (RF) technology to enable the accurate measurement of the time-of-flight of a radio signal and UWB positioning can operate in Time-Difference-of-Arrival (TDoA) mode, Two-Way-Ranging (TWR) mode, and Phase-Difference-of-Arrival (PDoA) mode. The systems disclosed herein include multiple anchor devices having a UWB antenna(s) and positioned in fixed location(s) over the fluid to be measured. The anchor devices serve as reference points for UWB communication with a remote float device, which emits RF signals and floats on the surface of the fluid to be measured.

Abstract: Provided herein are (alpha-substituted aralkylamino or heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, e.g., a compound of Formula I, and their pharmaceutical compositions, preparation, and use as agents or drugs for treating proliferative diseases.

Abstract: The invention regards a gas turbine engine control system and a method for limiting turbine overspeed in case of a shaft failure. The control system includes: an overspeed protection system that activates an activation member in case a shaft failure is detected; a fuel limiting mechanism coupled with the activation member, wherein the fuel limiting mechanism is configured to limit the fuel supply to the gas turbine engine combustor if the activation member is activated; a variable stator vane mechanism which is configured to adjust variable stator vanes of a compressor of the gas turbine engine in their rotational position, the variable stator vanes having a closed position which blocks air flow through the compressor.

Abstract: A high-efficient particulate air filter assembly including a high efficient particulate air filter for filtering the intake air as it enters an air purifying system is provided. The air filter assembly can further include a housing configured for use in an air purification system; a first prefilter positioned in the housing upstream from the particulate air filter; and an electrostatically charged substrate positioned in the housing downstream from the particulate air filter. The air filter assembly can further include a second prefilter having a paper layer; a carbon layer; a zeolite layer; a mesh layer; and a foam layer.

Abstract: Embodiments described herein provide for the leveraging of edge-based resources (e.g., processing, memory, storage, and/or other resources of one or more Multi-Access/Mobile Edge Computing devices (“MECs”), such as MECs associated with a radio access network (“RAN”) of a wireless network) to process data from and/or provide instructions to microcontroller devices, System on Chip (“SoC”) devices, configurable logic boards, Internet of Things (“IoT”) devices, and/or other types of devices or systems. For example, embodiments described herein may provide for the creation and configuration of logical devices or systems based on one or more microcontrollers, SoC devices, etc., edge-based processing of sensor data and/or other types of data received or generated by the microcontrollers, SoC devices, etc., and the generation of instructions to control physical devices communicatively coupled to the microcontrollers, SoC devices, etc.

Abstract: According to an aspect of the present disclosure, a method of treating a textile with an antimicrobial agent over a plurality of laundry cycles each including a wash cycle and a treatment cycle. The method includes (a) receiving a textile in a wash system for a first laundry cycle, (b) initiating a wash cycle comprising a detergent, (c) initiating a post-detergent treatment cycle comprising dosing the textile with a solution having a predetermined concentration of an antimicrobial agent that comprises a metallic ion, and (c) repeating steps (a)-(c) for each of a plurality of additional laundry cycles. The predetermined concentration is insufficient to achieve a predetermined antimicrobial efficacy for the textile due to the first laundry cycle alone but sufficient to achieve the predetermined antimicrobial efficacy for the textile due to a combination of the first laundry cycle and one or more of the plurality of additional laundry cycles.

Abstract: Disclosed is a method for producing deposition particles or intermediate particles, characterized in that the method comprises: forming a solution comprising a solvent and one or more deposit sources, aerosolizing the formed solution to produce an aerosol of precursor particles comprising the deposit source, conditioning the precursor particles to produce deposition particles or intermediate particles from the deposit source and collecting said particles. The particles may be collected as a deposit or precursor deposit on a substrate. The particles may include a matrix material and a dopant. The conditioning may be quenched to produce a desired substructure. The matrix material may be essentially optically clear. The substrate may comprise an optical fiber or an optical fiber preform or mandrel.

Abstract: The present invention relates to amitriptyline or a pharmaceutically acceptable sale thereof, for use in the treatment of Pitt-Hopkins syndrome.

Abstract: Systems, methods and computer-readable storage media can be used to debug content items. One example method includes presenting, by a mobile application executing on a mobile device, a first application interface. The example method further includes detecting, by the mobile device, a predetermined user action. The example method further includes, in response to detecting the predetermined user action, generating debugging information from content event logs, wherein the content event logs are associated with content item slots in which content items are presented in the mobile application and presenting, by a debugging interface, the debugging information.

Abstract: The present invention relates to minocycline or a pharmaceutically acceptable sale thereof, for use in the treatment of Pitt-Hopkins syndrome.

Abstract: Devices can be implanted in an eye to treat glaucoma and/or dry eye. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The body can include a radiused distal edge. A distal end portion of the body can be laterally flared. The body can include a mid-body portion that is laterally narrower than distal and proximal end portions of the body. Methods of treating glaucoma and/or dry eye, wherein the device is implanted in the sclera of an afflicted eye, are also described.

Abstract: An electrochemical cell for a secondary battery, preferably for use in an electric vehicle, is provided. The cell includes a solid metallic anode, which is deposited over a suitable current collector substrate during the cell charging process. Several variations of compatible electrolyte are disclosed, along with suitable cathode materials for building the complete cell.

Abstract: The method of manufacturing a magnetic rotor unit comprises providing a composite magnetic rotor body. The composite magnetic rotor body comprises magnetic particles dispersed in a polymer resin. The composite magnetic rotor body has a hole. The method further comprises inserting a shaft into the hole. The outer diameter of the shaft corresponds to the inner diameter of the hole. The method further comprises heating of the shaft. By heating the shaft, the elevated temperature of the shaft surface preferentially induces the polymer resin from an inner surface of the hole to exude or sweat on to the shaft surface, so as to provide a bonding layer between the magnetic rotor body and the shaft. An apparatus for such manufacture, and a magnetic rotor unit manufactured by such method, are also provided. Such rotor units have wide application, and may for example be used in sensors, electromagnetic generators, pulse generators, motors, magnetic brakes and magnetic couplings.

Abstract: A front end structure of a vehicle is disclosed and includes a housing having a fluid reservoir portion, a fan shroud portion, a back face, a bolster portion, a first air passage communicating airflow to an air intake system, and a second air passage in communication with a higher pressure airflow. A fan assembly is mounted within the fan shroud portion and a radiator mounted to the back face of the housing. A battery compartment is in communication with airflow from the second air passage for maintain battery temperature within a predefined range. A headlight also receives an airflow to actively remove moisture from an inner cavity. A method of assembling a front end structure is also disclosed.